Table 2.

Event Rate of Different Outcomes in Oral Anticoagulant Users and Antiplatelet Agent Users

Outcome	Oral anticoagulants (n=283)	Antiplatelet therapy (n=214)	Adjusted HR
Ischemic stroke			0.66 (0.37–1.19)
No. of events	10	19
Person‐y	327.18	510.83
Event rate (95% CI)	30.56 (16.45–56.81)	37.19 (23.72–58.31)
Thromboembolism			0.54 (0.32–0.91)
No. of events	12	25
Person‐y	325.29	493.60
Event rate (95% CI)	36.89 (20.95–64.96)	50.65 (34.22–74.96)
Intracerebral hemorrhage			0.42 (0.18–0.99)
No. of events	4	11
Person‐y	335.15	532.05
Event rate (95% CI)	11.94 (4.48–31.80)	20.67 (11.45–37.33)
Major bleeding event			0.97 (0.57–1.64)
No. of events	11	19
Person‐y	328.33	526.19
Event rate (95% CI)	33.50 (18.55–60.50)	36.11 (23.03–56.61)
All‐cause mortality			0.96 (0.73–1.25)
No. of events	48	76
Person‐y	336.22	540.83
Event rate (95% CI)	142.77 (107.59–189.45)	140.52 (112.23–175.95)

HR indicates hazard ratio.